|
WO2017061125A1
|
|
Therapy, diagnosis, and screening using card14
|
|
WO2017047095A1
|
|
Optimization of physiological properties of calcium phosphate as vaccine adjuvant
|
|
WO2017175253A1
|
|
Exosome-targeted dna vaccine
|
|
WO2016152767A1
|
|
CpG SPACER-OLIGONUCLEOTIDE-CONTAINING COMPLEX HAVING IMMUNOPOTENTIATING ACTIVITY, AND USE OF SAME
|
|
WO2016103703A1
|
|
Non-aggregating immunostimulatory oligonucleotides
|
|
WO2015182121A1
|
|
Method for examining allergy-inducing substance and diagnosis and treatment of allergy
|
|
WO2016079899A1
|
|
NOVEL Th1-INDUCING ADJUVANT COMPRISING COMBINATION OF DIFFERENT NUCLEIC ACID ADJUVANTS, AND USE OF SAME
|
|
WO2016103531A1
|
|
Use of nucleic acid-polysaccharide complexes having immunopotentiating activity as anti-tumor drug
|
|
US2016046904A1
|
|
Method For Culturing Hepatoblast-Like Cells And Culture Product Thereof
|
